NL-OMON54726招募中不适用
Identification of paediatric Hodgkin lymphoma biomarkers and novel therapeutic targets. - Hodgkin-biomarkers
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 230
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 17（—）
入选标准
- •In order to be eligible to participate in the Hodgkin lymphoma group, a subject
- •must meet all of the following criteria:
- •Diagnosis of classical Hodgkin Lymphoma confirmed by reference pathology
- •Patient aged below 18 at time of diagnosis
- •· Treatment according the European Network of Paediatric Hodgkin`s Lymphoma
- •Second International Inter-Group Study for Classical Hodgkin*s Lymphoma in
- •Children and Adolescents (EuroNet-PHL-C2) protocol or treatment for relapsed or
- •refractory patients or according to the Open-label, Uncontrolled, Multicenter
- •Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults with
- •Newly Diagnosed Classical Hodgkin Lymphoma with Inadequate (Slow Early)
- •Response to Frontline Chemotherapy.
- •Written informed consent of the patient and/or the patient's parents or
- •guardians according to national laws
排除标准
- •- HIV positivity
- •- Other underlying immunologic disorders causing an inadequate or overactive
- •immune response, with the exception of Epstein Barr Virus
研究者
相似试验
招募中
不适用
Hodgkin-biomarkersPediatric Hodgkin lymphomaNL-OMON28180Erasmus MC - Sophia320
进行中（未招募）
1 期
EuroNet-Paediatric Hodgkin?s Lymphoma Group First international Inter-Group Studyfor nodular lymphocyte-predominant Hodgkin?s Lymphoma in Children and Adolescents - EuroNet-PHL-LP1EUCTR2007-004092-19-NLMartin Luther University of Halle/Wittenberg
进行中（未招募）
1 期
EuroNet-Paediatric Hodgkin?s Lymphoma Group First international Inter-Group Study for classical Hodgkin?s Lymphoma in Children and Adolescents - EuroNet-PHL-C11st and 2nd line therapy for childhood Hodgkin?s lymphoma shall be further optimised to avoid over-treatment and decrease long-term complications.MedDRA version: 8.1 Level: HLGT Classification code 10025319 Term: Lymphomas Hodgkin's diseaseEUCTR2006-000995-33-NLMartin-Luther-University Halle-Wittenberg1,200
进行中（未招募）
1 期
EuroNet-Paediatric Hodgkin’s Lymphoma Group First international Inter-Group Studyfor nodular lymphocyte-predominant Hodgkin’s Lymphoma in Children and Adolescents - EuroNet-PHL-LP1The first line therapy for childhood nodular lymphocyte-predominant Hodgkin’s lymphoma shall be further optimised to avoid over-treatment and decrease long-term complications.EUCTR2007-004092-19-CZMartin Luther University of Halle/Wittenberg250
进行中（未招募）
1 期
Evaluation of the therapy of Hodgkin’s Lymphoma in Children and AdolescentsEUCTR2007-004092-19-DEMartin Luther University of Halle/Wittenberg200